| Jordan Talmage Huber, MD | |
|
1350 N 500 E, Logan, UT 84341-2400 | |
| (435) 716-1770 | |
| Not Available |
| Full Name | Jordan Talmage Huber |
|---|---|
| Gender | Male |
| Speciality | Dermatology |
| Experience | 7 Years |
| Location | 1350 N 500 E, Logan, Utah |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1598291361 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 57079 (Arizona) | Secondary |
| 207N00000X | Dermatology | 11659150-1205 (Utah) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Logan Regional Hospital | Logan, UT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Intermountain Healthcare Services, Inc | 1850209420 | 3063 |
News Archive
Getting access to health insurance, and getting access to a doctor, are two very different things. But a new University of Michigan study suggests that the two have gone hand-in-hand in the state of Michigan, despite a rapid influx of hundreds of thousands of newly insured people under the state's expansion of Medicaid.
Rib-X Pharmaceuticals, Inc., today announced that the Food and Drug Administration (FDA) designated delafloxacin as a Qualified Infectious Disease Product (QIDP) for the indications of acute bacterial skin and skin structure infections (ABSSSI) and community-acquired bacterial pneumonia (CABP).
The human immune system is in a perpetual state of self-experimentation. It expertly mutates and shuffles the DNA of its own cells to evolve new defenses against the vast array of microbes that try to invade our bodies.
Ludwig Cancer Research scientists have developed a new and more accurate method to identify the molecular signs of cancer likely to be presented to helper T cells, which stimulate and orchestrate the immune response to tumors and infectious agents.
› Verified 1 days ago
| Entity Name | Ihc Health Services Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1942325154 PECOS PAC ID: 1850209420 Enrollment ID: O20080610000303 |
News Archive
Getting access to health insurance, and getting access to a doctor, are two very different things. But a new University of Michigan study suggests that the two have gone hand-in-hand in the state of Michigan, despite a rapid influx of hundreds of thousands of newly insured people under the state's expansion of Medicaid.
Rib-X Pharmaceuticals, Inc., today announced that the Food and Drug Administration (FDA) designated delafloxacin as a Qualified Infectious Disease Product (QIDP) for the indications of acute bacterial skin and skin structure infections (ABSSSI) and community-acquired bacterial pneumonia (CABP).
The human immune system is in a perpetual state of self-experimentation. It expertly mutates and shuffles the DNA of its own cells to evolve new defenses against the vast array of microbes that try to invade our bodies.
Ludwig Cancer Research scientists have developed a new and more accurate method to identify the molecular signs of cancer likely to be presented to helper T cells, which stimulate and orchestrate the immune response to tumors and infectious agents.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jordan Talmage Huber, MD Po Box 27128, Slc, UT 84127-0128 Ph: (435) 716-1770 | Jordan Talmage Huber, MD 1350 N 500 E, Logan, UT 84341-2400 Ph: (435) 716-1770 |
News Archive
Getting access to health insurance, and getting access to a doctor, are two very different things. But a new University of Michigan study suggests that the two have gone hand-in-hand in the state of Michigan, despite a rapid influx of hundreds of thousands of newly insured people under the state's expansion of Medicaid.
Rib-X Pharmaceuticals, Inc., today announced that the Food and Drug Administration (FDA) designated delafloxacin as a Qualified Infectious Disease Product (QIDP) for the indications of acute bacterial skin and skin structure infections (ABSSSI) and community-acquired bacterial pneumonia (CABP).
The human immune system is in a perpetual state of self-experimentation. It expertly mutates and shuffles the DNA of its own cells to evolve new defenses against the vast array of microbes that try to invade our bodies.
Ludwig Cancer Research scientists have developed a new and more accurate method to identify the molecular signs of cancer likely to be presented to helper T cells, which stimulate and orchestrate the immune response to tumors and infectious agents.
› Verified 1 days ago
Dr. Nathan William Hanson, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 1350 N 500 E, Logan, UT 84341 Phone: 435-752-0422 |